Verstraete, M., Vermylen, J., Donati, M.B.: The effect of streptokinase infusion on chronic arterial occlusions and stenoses. AnnIntern. Med. , 74: 377, 1971.
2.
Martin, M., Schoop, W., Zeitler, E.: Streptokinase in chronic arterial occlusive disease. J.A.M.A. , 211: 1169, 1970.
3.
LeVeen, H.H. , Diag, C.A.: Venous and arterial occlusive disease treated by enzymatic clot lysis. Arch. Surg.,105: 927, 1972 .
4.
Hume, M., Gurewich, V., Thomas, D.P., et al.: Streptokinase for chronic arterial occlusive disease. Arch. Surg., 101: 653, 1970.
5.
Zeitler, E., Martin, M., Schoop, W.: Angiographische Befunde bei chronischer arterieller Verschlusskrankheit vor und nach Streptokinasebehandlung. Fortschr. Geb. Roentgenstr. Nuklearmed.,111: 498, 1969.
6.
Anderson, D.C. , Martin, A.M., Clunie, G.J.A., et al.: Eight months experience in the use of streptokinase locally for de-clotting arteriovenous cannulae. Proc. Eur. Dial. Transplant. Assoc.,4: 55, 1968.
7.
Arisz, L., Tegzess, A.M., Donker, A.J.M., et al.: The use of streptokinase in obstructed arteriovenous shunts . Postgrad. Med. J., 49: 99, 1973 (Suppl. 5).
8.
Cocke, T.B., Burgos-Calderon, R.A., Gonzalez, F.M.: The use of streptokinase infusions for arteriovenous shunt declotting. Trans. Am. Soc. Artif. Organs, 16: 292, 1970.
9.
Dotter, C.T. , Rosch, J., Seaman, A.J., et al.: Streptokinase treatment of thromboembolic disease. Radiology, 102: 283, 1972.
10.
Epstein, J. , Saker, B., Marshall, V., et al.: Treatment of clotting in external arteriovenous shunts with a fibrinolytic enzyme. Med. J. Aust.,2: 137, 1969.
11.
Gonzalez, F.M. , Cocke, T.B.: Use of streptokinase in occluded arteriovenous shunts. Thromb. Diath. Haemorrh. Suppl.,47: 201, 1971.
12.
Kjellstrand, C.M., Lindergard, B., Boijsen, E.: Treatment of clotted Quinton-Scribner arteriovenous shunts by streptokinase (Kabikinase). Results evaluated by angiographic and resistance studies. Proc. Eur. Dial. Transplant. Assoc.,4: 61, 1968.
13.
Koestering, H., Mietzsch, G., Wigger, W., et al.: Thrombolysis for removal of thrombotic-occlusions in the Cimino-shunt in hemodialysis patients. Med. Klin., 67: 945, 1972.
14.
Massey, W.H. , Seaman, A.J., Dotter, C.T., et al.: Re-evaluation of streptokinase therapy in intra-vascular thrombosis. Rev. Surg.,29: 142, 1972.
15.
Cassady, J.V. : Central retinal vein thrombosis. Am. J. Pathol., 36: 331, 1953.
16.
Vermas, S., Roitta, C.: Anticoagulant treatment of retinal vascular occlusion. Am. J. Ophthalmol., 62: 874, 1966.
Bergstein, J.M., Edson, J.R., Michael, A.F.: Fibrinolytic treatment of the haemolytic-uraemic syndrome. Lancet,1: 448, 1972.
19.
Monnens, L. , Kleynen, F., van Munster, P., et al.: Coagulation studies and streptokinase therapy in the haemolytic-uraemic syndrome. Helv. Paediatr. Acta,27: 45, 1972.
20.
Winterborn, M.H. , White, R.H.R., Stuart, J.: Fibrinolytic treatment of the haemolytic-uraemic syndrome. Lancet, 2: 1071, 1972.
21.
Powell, H.R., Ekert, M.B.: Streptokinase and anit-thrombotic therapy in the hemolyticuremic syndrome . J. Pediatr., 84: 345, 1974.
22.
Stuart, J., Winterborn, M.H., White, R.H.R., et al.: Thrombolytic therapy in haemolytic-uraemic syndrome. Br. Med. J., 3: 217, 1974.
23.
Bergstein, J. M.: Unpublished data.
24.
Bruhn, H.D.: On the significance of "anti-streptokinase" in streptokinase-induced thrombolytic therapy. Thromb. Diath. Haemorrh.,30: 221, 1973.
25.
Hirsch, J.: Dosage regimens for streptokinase treatment: Evaluation of a standard dosage schedule. Aust. Ann. Med., 19: 12, 1970.
26.
James, D.C.O. : Anti-streptokinase levels in various hospital patient groups. Postgrad. Med. J.49: 26, 1973, Suppl. 5.
27.
Flute, P.T. : The significance of streptokinase antibody . Postgrad. Med. J., 49: 24, 1973, Suppl. 5.
28.
Ronneberger, H.: Behringwerke AG, Marburg/Lahn, W. Germany. Personal communication.